Stock research report available on Amylin Pharmaceuticals (NASDAQ:AMLN) from SmarTrend Analytics
AMLN | Quote | Chart | News | PowerRating -- SmarTrend, the proprietary pattern recognition system, has made available a free sample copy of our premium research report on (NASDAQ:AMLN) at http://www.mysmartrend.com/research/
SmarTrend, our proprietary pattern recognition system, called an Uptrend for Amylin Pharmaceuticals (NASDAQ:AMLN) on November 17, 2009 at $13.01. Since then, Amylin Pharmaceuticals has returned 7.1% as of today's recent price of $13.93.
Want access to these reports and real time alerts? Go to www.tradethetrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
For full details on Amylin Pharmaceuticals (AMLN) AMLN. Amylin Pharmaceuticals (AMLN) has Short Term PowerRatings at TradingMarkets. Details on Amylin Pharmaceuticals (AMLN) Short Term PowerRatings is available at This Link.
- Amylin Pharmaceuticals Upward Momentum Looks to Continue (AMLN) - 02/09/10
- SmarTrend's Trend Spotter Sees Continued Upward Momentum on Shares of Amylin Pharmaceuticals (AMLN) - 02/03/10
- Amylin Pharmaceuticals (AMLN) Corporate Event Announcement Notice - 01/28/10
- Amylin Pharmaceuticals (AMLN) Corporate Event Announcement Notice - 01/27/10
- Amylin Q4 Loss Narrows - Update - 01/27/10
- More News >>


